Cocrystal Pharma, Inc. (COCP) Misses Q2 EPS by 21c

Cocrystal Pharma, Inc. (NASDAQ: COCP) reported Q2 EPS of ($0.25), $0.21 worse than the analyst estimate of ($0.04).

For earnings history and earnings-related data on Cocrystal Pharma, Inc. (COCP) click here.

You May Also Be Interested In

• Tesla plans 'flying' Roadster stunt at SpaceX Texas site as early as August
• Edible Garden AG (EDBL) Reports Q2 Loss of $18.79
• Cisco rating cut at HSBC as analyst sees a lack of catalysts